Published in Prog Neuropsychopharmacol Biol Psychiatry on February 01, 2001
A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry (2010) 2.02
The behavioural effects of pramipexole, a novel dopamine receptor agonist. Eur J Pharmacol (1997) 0.90
A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist. Behav Pharmacol (2002) 0.89
Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol (1992) 0.87
Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system. Neuropharmacology (2001) 0.86
Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1990) 0.86
The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm (1993) 0.86
Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine. J Physiol Pharmacol (2004) 0.85
Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors. J Neurochem (2006) 0.85
The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan. Pol J Pharmacol Pharm (1979) 0.83
Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands. Pol J Pharmacol (1997) 0.83
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity. Eur J Pharmacol (1982) 0.80
The effect of repeated treatment with pramipexole on the central dopamine D3 system. J Neural Transm (Vienna) (2000) 0.80
The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology (Berl) (1996) 0.79
Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists. Pol J Pharmacol (1996) 0.79
Synergistic effect of pramipexole and sertraline in the forced swimming test. Pol J Pharmacol (2000) 0.79
Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. Pol J Pharmacol (1995) 0.79
The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. J Neural Transm (Vienna) (1996) 0.78
Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems. J Neural Transm (Vienna) (1999) 0.78
Effect of tianeptine and fluoxetine on the levels of Met-enkephalin and mRNA encoding proenkephalin in the rat. J Physiol Pharmacol (2002) 0.78
Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist. Pol J Pharmacol (1996) 0.78
Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors. Behav Pharmacol (2002) 0.78
Antidepressant activity of S-adenosyl-L-methionine in mice and rats. J Basic Clin Physiol Pharmacol (1992) 0.78
The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system. J Neural Transm Gen Sect (1991) 0.77
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved? J Neural Transm (Vienna) (1999) 0.77
Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats. Pol J Pharmacol (1998) 0.77
The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Pol J Pharmacol Pharm (1993) 0.77
The effect of imipramine on the amount of mRNA coding for rat dopamine D2 autoreceptors. Eur J Pharmacol (1997) 0.77
Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test. Pol J Pharmacol (1998) 0.77
The role of dopamine D2 receptor in the behavioral effects of imipramine--study with the use of antisense oligonucleotides. J Physiol Pharmacol (2000) 0.77
The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats. J Physiol Pharmacol (2006) 0.77
Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. Eur J Pharmacol (1998) 0.77
Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. Pol J Pharmacol (1994) 0.77
Synergistic effect of amantadine and imipramine in the forced swimming test. Pol J Pharmacol (2001) 0.77
Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain. Eur J Pharmacol (1996) 0.76
Reserpine-induced locomotor stimulation in mice chronically treated with typical and atypical antidepressants. Eur J Pharmacol (1983) 0.76
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J Neural Transm Park Dis Dement Sect (1993) 0.76
Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat. Pol J Pharmacol (1999) 0.76
Effect of repeated treatment with milnacipran on the central dopaminergic system. Pol J Pharmacol (2001) 0.76
Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol (1984) 0.76
Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems. J Neural Transm (Vienna) (2000) 0.76
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Neuropharmacology (1992) 0.76
The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice. Pol J Pharmacol Pharm (1990) 0.76
Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. J Physiol Pharmacol (2002) 0.76
Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine. J Neural Transm (1984) 0.76
Effects of antihistaminic drugs in tests for antidepressant action. Pol J Pharmacol Pharm (1981) 0.75
Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity. Eur J Pharmacol (1996) 0.75
Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats. J Physiol Pharmacol (2003) 0.75
EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system. Pol J Pharmacol (1998) 0.75
Antidepressant effects of pramipexole, a novel dopamine receptor agonist. J Neural Transm (Vienna) (1997) 0.75
Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats. J Neural Transm Gen Sect (1991) 0.75
Neuropsychopharmacological profile of remoxipride in comparison with clozapine. Pol J Pharmacol (1998) 0.75
Central action of ketotifen. Pol J Pharmacol Pharm (1981) 0.75
Locomotor hyperactivity induced by MK-801 in rats. Pol J Pharmacol Pharm (1992) 0.75
Effect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393. Pol J Pharmacol Pharm (1990) 0.75
The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central alpha1-adrenergic system in rats. Behav Pharmacol (2004) 0.75
Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation. J Neural Transm (Vienna) (1998) 0.75
Some central effects of tiflucarbine, a new potential antidepressant drug. Pol J Pharmacol Pharm (1987) 0.75
Antidepressant activities of WEB 1881, a new nootropic agent. Pol J Pharmacol Pharm (1990) 0.75
Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system. Pharmacopsychiatry (1997) 0.75
Roxindole, a potential antidepressant. I. Effect on the dopamine system. J Neural Transm (Vienna) (1996) 0.75
The effect of the antihistaminic drugs on the central action of 5-hydroxytryptophan in mice. Pol J Pharmacol Pharm (1981) 0.75
Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes. Arzneimittelforschung (1994) 0.75
The effect of proadifen, a drug metabolism inhibitor, on action of imipramine and desipramine in mice. Pol J Pharmacol Pharm (1983) 0.75
5-Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors. J Pharm Pharmacol (1983) 0.75
Histidine-induced bizarre behaviour in rats: the possible involvement of central cholinergic system. Neuropharmacology (1982) 0.75
Synthesis and pharmacologic properties of pyridoyl derivatives of 3-methylaminoindole 2-methyltryptamine and isotryptamine. Arch Immunol Ther Exp (Warsz) (1976) 0.75
Pharmacological and biochemical studies on binodaline. Arzneimittelforschung (1983) 0.75
Central action of amitriptyline N-oxide. Pharmacopsychiatria (1982) 0.75
Some central effects of opipramol given repeatedly. Pol J Pharmacol Pharm (1991) 0.75
Some central effects of impromidine, a potent agonist of histamine H2 receptors. Neuropharmacology (1980) 0.75
Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain. J Neural Transm (Vienna) (1997) 0.75
Incorporation and utilization in hematopoietic processes of iron ( 59 Fe) administered intragastrically in the form of various compounds to suckling pigs. Bull Acad Pol Sci Biol (1973) 0.75
On the central antiserotonin action of trazodone. Pol J Pharmacol Pharm (1979) 0.75
Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice. J Neural Transm (1982) 0.75
Central action of pirenzepine. Pol J Pharmacol Pharm (1981) 0.75
(+)-Oxaprotiline but not (-)-oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidine. J Pharm Pharmacol (1983) 0.75
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice. Pol J Pharmacol Pharm (1983) 0.75
Influence of proadifen, an inhibitor of the metabolism of drugs, on the action of imipramine and desipramine in rats. Pol J Pharmacol Pharm (1981) 0.75
Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist. J Neural Transm Gen Sect (1989) 0.75
Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors. J Neural Transm Gen Sect (1990) 0.75
Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice. Pol J Pharmacol (1994) 0.75
Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effects. Pol J Pharmacol (1993) 0.75
Central effects of Ro 19-6327 given acutely and repeatedly. Pol J Pharmacol Pharm (1992) 0.75
Central action of the antidepressant drug pirlindole. Arzneimittelforschung (1986) 0.75